MarketPeel
Insider Trading Intelligence
RL

Robert P. Lenk

PSTV
DIRECTOR · PLUS THERAPEUTICS, INC. · CIK 0001362635
FILING MIX · LIFETIME95%/5%
BUYS
19
SELLS
1
TOTAL VALUE
$122.4K
COMPANIES
1
ACTIVE SINCE
Jun 2020
HOLDINGS NOW
139,327
AVG SELL PX
$0.31
TRADE KIND
SHOWING 20 / 20
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
13 backtested trades · 8 horizons · 2 pending
Forward-return performance of every backtestable P/S trade by Robert P. Lenk, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d13+53.85%+14.62%+1.69%+12.93%+7.41%
14d13+61.54%+9.17%+2.25%+6.93%+9.14%
30d13+69.23%+18.67%+3.48%+15.19%+18.36%
60d13+69.23%+10.18%+6.50%+3.68%+3.20%
90d13+53.85%+5.03%+9.40%-4.37%-2.01%
180d13+69.23%+7.94%+14.44%-6.50%-2.99%
1y13(1 pending)+16.67%+22.10%+29.02%-6.92%-53.50%
2y13(1 pending)+83.33%+474.56%+48.44%+426.12%+556.08%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
PSTV · 139,327 shares · as of Aug 22, 2025
074,449148,897223,346297,79420212022202320242025SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
FLOW · 19 buys / 1 sellsCOVERAGE · 22 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
PSTV
PLUS THERAPEUTICS, INC.
PURCHASE
110,000$0.49$53.8K139,327Aug 22, 2025Aug 25, 2025View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
297,794297,794Aug 13, 2025Aug 15, 2025View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
40,12240,122Feb 18, 2025Feb 20, 2025View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
3,6503,650Sep 11, 2024Sep 12, 2024View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASE
4,167$2.04$8.5K29,327May 8, 2024May 10, 2024View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
8,3348,334May 8, 2024May 10, 2024View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
2,2502,250Feb 22, 2024Feb 26, 2024View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASE
1,000$1.95$1.9K25,160Nov 16, 2023Nov 17, 2023View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASE
1,000$1.77$1.8K24,160Nov 15, 2023Nov 17, 2023View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASE
4,000$1.43$5.7K23,160Nov 13, 2023Nov 15, 2023View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASE
2,000$1.45$2.9K19,160Nov 10, 2023Nov 15, 2023View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASE
4,199$1.59$6.7K17,160Nov 9, 2023Nov 13, 2023View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASE
5,000$1.65$8.3K12,961Nov 8, 2023Nov 13, 2023View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASE
6,000$1.64$9.8K7,961Nov 7, 2023Nov 8, 2023View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASE
1,395$1.50$2.1K1,961Nov 6, 2023Nov 8, 2023View →
PSTV
PLUS THERAPEUTICS, INC.
SALE
1,500$0.31$4728,500Dec 30, 2022Jan 4, 2023View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASE
7,000$1.86$13.0K10,000Sep 13, 2021Sep 15, 2021View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
6,3366,336May 25, 2021May 27, 2021View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASE
3,000$2.49$7.5K3,000Aug 25, 2020Aug 26, 2020View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
40,00040,000Jun 25, 2020Jun 29, 2020View →
Other insiders · PSTV
Loading peer insiders…
About this filer
CIK 0001362635
ROLE
Director
PRIMARY
PSTV
COMPANIES
1
ACTIVE SINCE
Jun 2020
MARKETPEEL · /INSIDER/0001362635DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback